Djaina Satoer

Dr. Djaina Satoer

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2013 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
Djaina SatoerDjaina Satoer
Djaina Satoer
EVEvy Visch-Brink
Evy Visch-Brink
MSMarion Smits
Marion Smits
AKAlfred Kloet
Alfred Kloet
CLCaspar Looman
Caspar Looman
AVArnaud Vincent
Arnaud Vincent

4 May 2017 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
ARAdrià Rofes
Adrià Rofes
EMEmmanuel Mandonnet
Emmanuel Mandonnet
JGJohn Godden
John Godden
MBMarie Hélène Baron
Marie Hélène Baron
HCHenry Colle
Henry Colle
MWMichel Wager
Michel Wager

1 November 2012 in Journal of Neurosurgery
Verified
Journal Article
Closed access
Djaina SatoerDjaina Satoer
Djaina Satoer
JVJudith Vork
Judith Vork
EVEvy Visch-Brink
Evy Visch-Brink
MSMarion Smits
Marion Smits
CDClemens Dirven
Clemens Dirven
AVArnaud Vincent
Arnaud Vincent
Object: Patients with gliomas frequently have cognitive deficits, and surgery can exacerbate these deficits. Preoperative assessment is therefore crucial in patients undergoing surgery for glioma in eloquent areas, because the proximity of functional areas increases the risk of permanent postoperative cognitive disturbances. Although pre- and postoperative language and motor function in patients with glioma have been investigated frequently, data on good cognition studies are scarce. Most studies have focused on clinical neurological functioning or have only used brief neurological instruments. The authors investigated whether surgery for glioma in eloquent areas influences cognition early after surgery, by using an elaborate test protocol. Methods: Twenty-eight patients with gliomas of the left hemisphere in language and nonlanguage areas were assessed before and 3 months after surgery with a comprehensive neuropsychological test protocol. The authors performed a correlation analysis between change in cognitive performance and tumor characteristics (that is, location, volume, pathological features, and histological grade) and between cognitive change and treatment-related factors (the extent of the resection and postoperative treatment with chemo- and radiotherapy). Results: Both pre- and postoperatively, the mean performance of the patients was worse than the performance of the normal population in the language domain, the memory domain, and the executive functions (p < 0.05). Postoperatively, a decline was found in the language domain (t = 2.34, p = 0.027) and in the executive functions (t = 2.45, p = 0.022). However, cognitive change postsurgery was influenced by the location of the tumor; the decrease of cognitive score in the language domain was only observed in patients with tumors in or close to language areas (t = 2.33, p = 0.029). No effect on cognitive change was found for the other tumor characteristics and treatment-related factors. Conclusions: This study underlines the importance of the use of a neuropsychological test protocol before and after surgery in patients with glioma, because several tasks in the domains of language, memory, and executive functions appeared to deteriorate after surgery. Tumor resection in language areas increases the risk of cognitive deficits in the language domain postoperatively.

14 November 2015 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
Djaina SatoerDjaina Satoer
Djaina Satoer
EVEvy Visch-Brink
Evy Visch-Brink
CDClemens Dirven
Clemens Dirven
AVArnaud Vincent
Arnaud Vincent
Background Cognitive preservation is crucial in glioma surgery, as it is an important aspect of daily life functioning. Several studies claimed that surgery in eloquent areas is possible without causing severe cognitive damage. However, this conclusion was relatively ungrounded due to the lack of extensive neuropsychological testing in homogenous patient groups. In this study, we aimed to elucidate the short-term and long-term effects of glioma surgery on cognition by identifying all studies who conducted neuropsychological tests preoperatively and postoperatively in glioma patients. Methods We systematically searched the electronical databases Embase, Medline OvidSP, Web of Science, PsychINFO OvidSP, PubMed, Cochrane, Google Scholar, Scirius and Proquest aimed at cognitive performance in glioma patients preoperatively and postoperatively. Results We included 17 studies with tests assessing the cognitive domains: language, memory, attention, executive functions and/or visuospatial abilities. Language was the domain most frequently examined. Immediately postoperatively, all studies except one, found deterioration in one or more cognitive domains. In the longer term (3–6/6–12 months postoperatively), the following tests showed both recovery and deterioration compared with the preoperative level: naming and verbal fluency (language), verbal word learning (memory) and Trailmaking B (executive functions). Conclusions Cognitive recovery to the preoperative level after surgery is possible to a certain extent; however, the results are too arbitrary to draw definite conclusions and not all studies investigated all cognitive domains. More studies with longer postoperative follow-up with tests for cognitive change are necessary for a better understanding of the conclusive effects of glioma surgery on cognition.

1 December 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
AKAnne-Sophie C A M Koning
Anne-Sophie C A M Koning
MMMerel van der Meulen
Merel van der Meulen
DSDaphne Schaap
Daphne Schaap
Djaina SatoerDjaina Satoer
Djaina Satoer
CVChristiaan H Vinkers
Christiaan H Vinkers
ODOlaf M Dekkers
Olaf M Dekkers
Context: Synthetic glucocorticoids are widely used to treat patients with a broad range of diseases. While efficacious, glucocorticoids can be accompanied by neuropsychiatric adverse effects. Objective: This systematic review and meta-analysis assesses and quantifies the proportion of different neuropsychiatric adverse effects in patients using synthetic glucocorticoids. Methods: Six electronic databases were searched to identify potentially relevant studies. Randomized controlled trials, cohort studies, and cross-sectional studies assessing psychiatric side effects of glucocorticoids measured with validated questionnaires were eligible. Risk of bias was assessed with RoB 2, ROBINS-I, and AXIS appraisal tool. For proportions of neuropsychiatric outcomes, we pooled proportions, and when possible, differences in questionnaire scores between glucocorticoid users and nonusers were expressed as standardized mean differences (SMD). Data were pooled in a random-effects logistic regression model. Results: We included 49 studies with heterogeneity in study populations, type, dose, and duration of glucocorticoids. For glucocorticoid users, meta-analysis showed a proportion of 22% for depression (95% CI, 14%-33%), 11% for mania (2%-46%), 8% for anxiety (2%-25%), 16% for delirium (6%-36%), and 52% for behavioral changes (42%-61%). Questionnaire scores for depression (SMD of 0.80 [95% CI 0.35-1.26]), and mania (0.78 [0.14-1.42]) were higher than in controls, indicating more depressive and manic symptoms following glucocorticoid use. Conclusion: The heterogeneity of glucocorticoid use is reflected in the available studies. Despite this heterogeneity, the proportion of neuropsychiatric adverse effects in glucocorticoid users is high. The most substantial associations with glucocorticoid use were found for depression and mania. Upon starting glucocorticoid treatment, awareness of possible psychiatric side effects is essential. More structured studies on incidence and potential pathways of neuropsychiatric side effects of prescribed glucocorticoids are clearly needed.

26 February 2013 in Acta Neurochirurgica
Verified
Journal Article
Closed access
Djaina SatoerDjaina Satoer
Djaina Satoer
AVArnaud Vincent
Arnaud Vincent
MSMarion Smits
Marion Smits
CDClemens Dirven
Clemens Dirven
EVEvy Visch-Brink
Evy Visch-Brink